First Opinion

First Opinion

Aducanumab isn’t the simple solution to the complicated Alzheimer’s crisis

By Jason Karlawish

First Opinion

Orphan Drug Act’s ‘nonprofitability’ loophole needs to be closed

By Diane Dorman

First Opinion

Manufacturing: the next breakthrough in gene therapy

By Diane Blumenthal

First Opinion

Takeaways from a biotech CEO on the House’s passage of H.R. 3

By Paul Hastings

Artificial intelligence can help create a drug launch playbook.

First Opinion

Artificial intelligence and machine learning can be the backbones of a drug launch playbook

By Yilian Yuan and José Luis Fernández

First Opinion

The Consumer Product Safety Commission needs to act on major threats to children

By Kyle Yasuda

First Opinion

New drug development: ‘It’s the ecosystem, stupid’

By John Stanford

First Opinion

Deadline looms to stop the Health Insurance Tax — but Congress has been there before

By Allyson Y. Schwartz

First Opinion

Integrated care opens new doors to mental health, addiction care

By Matthew Press and Cecilia Livesey

First Opinion

BMJ should retract flawed research paper on chronic fatigue syndrome

By David Tuller

First Opinion

Congress: Don’t eliminate funding for the diversity creating Health Career Opportunity Program

By LaShyra Nolen

First Opinion

Machine learning for clinical decision-making: pay attention to what you don’t see

By Sherri Rose

First Opinion

More Americans are dying at home. Is that a good thing?

By Sarah H. Cross and Haider J. Warraich

First Opinion

Oral immunotherapy can be a game changer for many with food allergies

By Charles Feng

Standard Primary Care Doctor's Office Equipment

First Opinion

Survey of primary care physicians in 11 countries shows where U.S. is lagging and keeping pace

By Michelle Doty and David Blumenthal

First Opinion

Mental health and addiction care are poorly covered by insurance networks

By Patrick J. Kennedy

First Opinion

I thought patriarchy in science was fading. Then I saw it in the data

By Emma Thomas

First Opinion

Do large pharma companies provide drug development innovation? Our analysis says no

By Emily H. Jung, Alfred Engelberg, and Aaron S. Kesselheim

First Opinion

H.R. 3 is the wrong path to lower drug costs

By Mike Guerra

First Opinion

The EPA’s proposed ‘transparency rule’ will harm health, safety, and the environment

By Lenny Teytelman, William Gunn, and Joanne Kamens

First Opinion

Aducanumab: the beginning of the end of Alzheimer’s disease?

By Jason Karlawish

First Opinion

Cutting 700,000 Americans from SNAP will increase health costs

By Stephanie Ettinger de Cuba, Diana B. Cutts, and Allison Bovell-Ammon

First Opinion

Creating a Facebook for cell communication can help treat disease

By Virginia Savova

First Opinion

Step aside, biomarkers. Look to the bank account for early signs of dementia

By Eric Chess

First Opinion

U.S. continues to lead the fight against antibiotic resistance

By Alex M. Azar II and Robert R. Redfield

To make advanced therapies, we need to industrialize personalization

Tech and health care need their own ‘Hippocratic oath’ to make digital health work

Biologics lose protection as U.S.-Canada-Mexico trade agreement moves forward

A hospital staffer diverted drugs, which gave me hepatitis C. That happens more often than you think

Aducanumab isn’t the simple solution to the complicated Alzheimer’s crisis

Orphan Drug Act’s ‘nonprofitability’ loophole needs to be closed

Manufacturing: the next breakthrough in gene therapy

Takeaways from a biotech CEO on the House’s passage of H.R. 3

Artificial intelligence and machine learning can be the backbones of a drug launch playbook

The Consumer Product Safety Commission needs to act on major threats to children

New drug development: ‘It’s the ecosystem, stupid’

Deadline looms to stop the Health Insurance Tax — but Congress has been there before

Integrated care opens new doors to mental health, addiction care

BMJ should retract flawed research paper on chronic fatigue syndrome

Congress: Don’t eliminate funding for the diversity creating Health Career Opportunity Program

Machine learning for clinical decision-making: pay attention to what you don’t see

More Americans are dying at home. Is that a good thing?

Oral immunotherapy can be a game changer for many with food allergies

Survey of primary care physicians in 11 countries shows where U.S. is lagging and keeping pace

Mental health and addiction care are poorly covered by insurance networks

I thought patriarchy in science was fading. Then I saw it in the data

Do large pharma companies provide drug development innovation? Our analysis says no

H.R. 3 is the wrong path to lower drug costs

The EPA’s proposed ‘transparency rule’ will harm health, safety, and the environment

Aducanumab: the beginning of the end of Alzheimer’s disease?

Cutting 700,000 Americans from SNAP will increase health costs

Creating a Facebook for cell communication can help treat disease

Step aside, biomarkers. Look to the bank account for early signs of dementia

U.S. continues to lead the fight against antibiotic resistance